Grade III Specialty · National Particle Therapy Flagship
Established
2015
Beds
220+
Annual Volume
1,200+
Shanghai
China’s first center with both proton and carbon-ion beams; 10,000+ patients treated, 5-year overall survival 70.4% (2026 survival report).
The Shanghai Proton and Heavy Ion Center (SPHIC, the particle-therapy center of Fudan University Shanghai Cancer Center) is China’s first facility offering both proton and carbon-ion therapy. Since opening in 2015 it has treated over ten thousand patients, ranking among the busiest particle centers worldwide.
Equipped with Siemens pencil-beam scanning, the hospital has built particle-therapy pathways for more than 40 tumor types and systematic data in nasopharyngeal, lung, liver and prostate cancers as well as pediatric tumors, together with mature international patient services and direct-billing insurance arrangements.
01Dual proton and carbon-ion platform
Within one center, physicians select the optimal modality between protons and carbon ions based on lesion location, histology and prior irradiation.
02Internationally published outcomes
Local-control and survival data for key diseases (nasopharyngeal, lung, prostate cancers) are published in international journals at an advanced level.
03One-stop international patient services
A dedicated international department provides English medical records, direct billing with multiple international insurers, accommodation and interpreting support, ensuring a smooth outpatient-based treatment experience.
By its 10th anniversary, the hospital had treated over 9,300 patients across 40+ tumor types; proton/heavy-ion therapy for locally advanced nasopharyngeal carcinoma achieved internationally leading 5-year overall survival.
Conducted a prospective clinical study of carbon-ion re-irradiation for recurrent nasopharyngeal carcinoma, significantly reducing severe re-irradiation toxicity; published in leading radiation oncology journals.